{"id":"W3094186674","doi":"10.1016/s1474-4422(20)30347-1","title":"Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Biotin and Related Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Ottawa Hospital; Montreal Neurological Institute and Hospital; University of Ottawa","funders":"National Institute of Biomedical Imaging and Bioengineering; MedDay Pharmaceuticals; Rosetrees Trust","keywords":"Medicine; Expanded Disability Status Scale; Multiple sclerosis; Placebo; Clinical endpoint; Clinical trial; Physical therapy; Internal medicine; Pediatrics; Surgery; Pathology; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002212692,0.0002042321,0.0006631759,0.00003076851,0.00008367799,0.00001035834,0.0002008229,0.0001984251,0.000006246069],"category_scores_gemma":[0.0001806094,0.000118169,0.00007816854,0.0001267741,0.0003251288,0.000003355627,0.0001461537,0.0002797111,0.000001977145],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000002421463,"about_ca_system_score_gemma":0.00002708344,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001213934,"about_ca_topic_score_gemma":0.00001327188,"domain_scores_codex":[0.9985852,0.0002758457,0.000357087,0.0003793583,0.0001066733,0.0002958197],"domain_scores_gemma":[0.9992366,0.0001542046,0.0002435205,0.0002425147,0.00005773785,0.00006537099],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9907844,0.0003849609,0.003973585,0.00001550115,0.0002609493,0.00000491684,0.0001646381,0.00008936495,0.003066578,0.00001397472,0.0001692699,0.001071848],"study_design_scores_gemma":[0.9849566,0.005318052,0.005821471,0.00001204072,0.00009778207,0.000002724959,0.00001269597,0.00008776207,0.002997617,0.000002403725,0.0005532468,0.0001375678],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993472,0.0007240892,0.00001480629,0.002889701,0.000128178,0.002643388,0.00003198353,0.00001294562,0.00008288661],"genre_scores_gemma":[0.998238,0.0004048945,0.00004634582,0.0009294568,0.0002327323,0.00007559804,0.00004399979,0.00001935427,0.000009673004],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005827777,"threshold_uncertainty_score":0.4818791,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02683076213583269,"score_gpt":0.2604312120596609,"score_spread":0.2336004499238282,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}